相似文献
1
Clinical pharmacology of chemotherapy agents in older people with cancer.
Curr Gerontol Geriatr Res. 2011;2011:628670. doi: 10.1155/2011/628670. Epub 2011 Aug 10.
2
Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol.
BMC Cancer. 2019 Nov 27;19(1):1153. doi: 10.1186/s12885-019-6377-7.
3
Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.
Br J Clin Pharmacol. 2011 Mar;71(3):351-64. doi: 10.1111/j.1365-2125.2010.03847.x.
4
Pharmacokinetics of chemotherapy in the older patient.
Cancer Control. 2007 Jan;14(1):32-43. doi: 10.1177/107327480701400105.
5
Chemotherapy in the geriatric population.
Clin J Oncol Nurs. 2004 Dec;8(6):591-7. doi: 10.1188/04.CJON.591-597.
6
Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review.
Eur Urol Focus. 2017 Oct;3(4-5):330-339. doi: 10.1016/j.euf.2017.10.010. Epub 2018 Jan 10.
7
Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.
Consult Pharm. 2008 Apr;23(4):324-34. doi: 10.4140/tcp.n.2008.324.
8
Clinical pharmacology in the geriatric patient.
Fundam Clin Pharmacol. 2007 Jun;21(3):217-30. doi: 10.1111/j.1472-8206.2007.00473.x.
9
[Medicinal treatment of pain in the elderly: 10 tips from clinical pharmacology]].
Ned Tijdschr Geneeskd. 2019 Jan 24;163:D2984.
10
Geriatric pharmacology for the dentist. An overview.
Dent Clin North Am. 1984 Jul;28(3):581-93.
引用本文的文献
1
Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.
Clin Transl Sci. 2018 Mar;11(2):123-146. doi: 10.1111/cts.12527. Epub 2017 Dec 19.
2
Polypharmacy in older adults: the role of the advanced practitioner in oncology.
J Adv Pract Oncol. 2013 Mar;4(2):107-12.
3
Potential drug interactions in patients with a history of cancer.
Curr Oncol. 2014 Apr;21(2):e212-20. doi: 10.3747/co.21.1657.
4
Do we protect or discriminate? Representation of senior adults in clinical trials.
Rep Pract Oncol Radiother. 2012 Sep 26;18(1):6-10. doi: 10.1016/j.rpor.2012.08.006. eCollection 2012.
本文引用的文献
1
Inflammation and immune system alterations in frailty.
Clin Geriatr Med. 2011 Feb;27(1):79-87. doi: 10.1016/j.cger.2010.08.002.
2
Caring for the elderly cancer patient: training the next generation of oncologists.
J Oncol Pract. 2008 Jul;4(4):193-4. doi: 10.1200/JOP.0841503.
3
Physiological aging in older adults with cancer: implications for treatment decision making and toxicity management.
J Gerontol Nurs. 2010 Feb;36(2):26-37; quiz 38-9. doi: 10.3928/00989134-20091103-98. Epub 2010 Feb 5.
4
Cancer chemotherapy in the older cancer patient.
Urol Oncol. 2009 Nov-Dec;27(6):633-42. doi: 10.1016/j.urolonc.2009.08.006.
5
Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy.
Curr Treat Options Oncol. 2008 Jun;9(2-3):191-203. doi: 10.1007/s11864-008-0060-6. Epub 2008 Jul 29.
6
Plasma esterases and inflammation in ageing and frailty.
Eur J Clin Pharmacol. 2008 Sep;64(9):895-900. doi: 10.1007/s00228-008-0499-1. Epub 2008 May 28.
7
Free drug metabolic clearance in elderly people.
Clin Pharmacokinet. 2008;47(5):297-321. doi: 10.2165/00003088-200847050-00002.
8
Body composition, changing physiological functions and nutrient requirements of the elderly.
Ann Nutr Metab. 2008;52 Suppl 1:2-5. doi: 10.1159/000115339. Epub 2008 Mar 7.
9
Aging and cancer cell biology, 2008.
Aging Cell. 2008 Jun;7(3):281-4. doi: 10.1111/j.1474-9726.2008.00383.x. Epub 2008 Mar 10.
10
Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
J Clin Oncol. 2008 Mar 10;26(8):1239-46. doi: 10.1200/JCO.2007.11.9081.
Zotero 插件